Department Announces New Investments to Advance Psychedelic Research, Including Ibogaine Development and Rapid-Acting Mental Health Treatments
November 13, 2026 | |
Department Announces New Investments to Advance Psychedelic Research, Including Ibogaine Development and Rapid-Acting Mental Health Treatments
The Department of Health and Human Services (HHS) announced two initiatives to advance research into psychedelic and other rapid-acting therapies for serious mental illness. The announcement includes an Advanced Research Projects Agency for Health (ARPA-H) investment of up to $4.9 million over five years to establish the scientific, regulatory, and manufacturing foundation for future U.S. clinical trials of ibogaine, particularly… (Colocho, November 13, 2026) #Grants, #Mental and Behavioral Health, #National Institutes of Health